• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】13533

【品名】(4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid

【CA登记号】

【 分 子 式 】C19H27NO3

【 分 子 量 】317.42832

【元素组成】C 71.89% H 8.57% N 4.41% O 15.12%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(VII)

L-654066 has been obtained by three related ways: 1) Reaction of methyl (5alpha)-3-oxo-4-azaandrostene-17beta-carboxylate (I) with potassium hydroxide, followed by treatment with pyridyl disulfide, gives S-(2-pyridyl) (5alpha)-3-oxo-4-azaandrostene-17beta-thiocarboxylate (II). Compound (II) is reacted with isobutylmagnesium chloride (III) in THF to give (5alpha)-23-methyl-4-aza-21-norcholane-3,20-dione (IV), which is finally dehydrogenated using benzeneseleninic anhydride in chlorobenzene. 2) Compound (I) is converted to its dehydro analogue methyl (5alpha)-3-oxo-4-azaandrost-1-ene-17beta-carboxylate (V) with benzeneselenic anhydride, followed by reaction with isobutylmagnesium bromide (VI) in THF in the presence of hexamethyldisilazane. 3) Reaction of (5alpha)-3-oxo-4-azaandrost-1-ene-17beta-carboxylic acid (VII) with carbonyldiimidazole in THF gives 1-[[(5alpha,17beta)-3-oxo-4-azaandrost-1-en-17-yl]carbonyl]-1H-imidazole (VII), which is treated with isobutylmagnesium chloride (III) in THF in the presence of ferric chloride.

1 Rasmusson, G.H.; Reynolds, G.F. (Merck & Co., Inc.); 17beta-Substd.-4-aza-5alpha-androstenones and their use as 5alpha-reductase inhibitors. AU 8539167; EP 0155096; EP 0314199; ES 8702430; JP 1985222497; JP 1989093600; US 4760071 .
2 Rasmusson, G.H.; Reynolds, G.F. (Merck & Co., Inc.); 17beta-Acyl-4-aza-5alpha-androst-1-en-3-ones as 5alpha-reductase inhibitors. EP 0271219; JP 1988139196 .
3 Gormley, G.J.; Stoner, E. (Merck & Co., Inc.); Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5alpha-reductase inhibitor and an antiandrogen. JP 1994506227; WO 9216213 .
4 Bhattacharya, A.; Dolling, U.H.; Amato, J.S.; Williams, J.M. (Merck & Co., Inc.); Methods of synthesizing benign prostatic hypertropic agents and their intermediates. EP 0367502 .
5 Williams, J.M. (Merck & Co., Inc.); Process for making 17-beta alkanoyl 3-oxo-4-aza-5-alpha-androst-1-enes. US 5061803 .
6 Rasmusson, G.H.; Reynolds, G.F.; Steinberg, N.G.; Walton, E.; Patel, G.F.; Liang, T.; Cascieri, M.A.; Cheung, A.H.; Brooks, J.R.; Berman, C.; Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding. J Med Chem 1986, 29, 11, 2298.
7 Bhattacharya, A.; Williams, J.M.; Amato, J.S.; Dolling, U.-H.; Grabowski, E.J.J.; Acylimidazolides as versatile synthetic intermediates for the preparation of sterically congested amides and ketones: A practical synthesis of Proscar(R). Synth Commun 1990, 30, 17, 2683.
8 Prous, J.; Mealy, N.; Castaner, J.; L-654066. Drugs Fut 1993, 18, 8, 701.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13527 methyl (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate C20H31NO3 详情 详情
(II) 13528 S-(2-pyridinyl) (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carbothioate C24H32N2O2S 详情 详情
(III) 13529 Chloro(isopentyl)magnesium C5H11ClMg 详情 详情
(IV) 13530 (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-7-(3-methylbutanoyl)hexadecahydro-2H-indeno[5,4-f]quinolin-2-one C23H37NO2 详情 详情
(V) 13009 methyl (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate C20H29NO3 详情 详情
(VI) 13532 Bromo(isopentyl)magnesium C5H11BrMg 详情 详情
(VII) 13533 (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid C19H27NO3 详情 详情
(VIII) 13534 (4aS,4bS,6aS,7S,9aS,9bS,11aR)-7-(1H-Imidazol-1-ylcarbonyl)-4a,6a-dimethyl-1,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-2H-indeno[5,4-f]quinolin-2-one C22H29N3O2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XIII)

2) The oxidation of 3-oxo-4-androstene-17beta-carboxylic acid (I) with KMnO4/NaIO4/Na2CO3 in refluxing tert-butanol/water affords the seco-steroid (VIII), which is cyclized with NH3 in ethylene glycol at 180 C, giving the 5-unsaturated steroid (IX). The hydrogenation of (IX) with H2 over PtO2 in acetic acid yields the saturated azasteroid (X), which is esterified with 2,2-dimethoxypropane/HCl in methanol to afford the corresponding methyl ester (XI). The dehydrogenation of (XI) with phenylseleninic anhydride in refluxing chlorobenzene gives the 1-unsaturated azasteroid (XII), which is hydrolyzed with KOH in refluxing methanol/water to yield the corresponding unsaturated free acid (XIII). The esterification of (XIII) with 2,2'-dipyridyl disulfide (XIV) by means of triphenylphosphine in toluene affords the 2-pyridyl thioester (XV), which is finally amidated with 2,5-bis(trifluoromethyl)aniline (III) by means of silver trifluomethanesulfonate in dichloromethane. 3) The previously obtained unsaturated free acid (XIII) can also be treated with SOCl2 in pyridine to give the corresponding acyl chloride (XVI), which is then condensed directly with 2,5-bis(trifluoromethyl)aniline (III) in pyridine.

1 Ellsworth, K.; Mosley, R.T.; Chang, B.; Rasmusson, G.H.; Harris, G.S.; Patel, G.F.; Tolman, R.L.; Bakshi, R.K.; 4-Aza-3-oxo-5alpha-androst-1-ene-17beta-N-aryl-car. J Med Chem 1995, 38, 17, 3189.
2 Graul, A.; Silvestre, J.S.; Castañer, J.; Dutasteride. Drugs Fut 1999, 24, 3, 246.
3 Rasmusson, G.H.; Reynolds, G.F.; Steinberg, N.G.; Walton, E.; Patel, G.F.; Liang, T.; Cascieri, M.A.; Cheung, A.H.; Brooks, J.R.; Berman, C.; Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding. J Med Chem 1986, 29, 11, 2298.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14892 (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid; 4-Androstene-3-oxo-17-beta-carboxylic acid 7385-78-6 C20H28O3 详情 详情
(III) 22446 2,5-bis(trifluoromethyl)phenylamine; 2,5-bis(trifluoromethyl)aniline 328-93-8 C8H5F6N 详情 详情
(VIII) 22451 (3S,3aS,5aS,6R,9aS,9bS)-6-(2-carboxyethyl)-3a,6-dimethyl-7-oxododecahydro-1H-cyclopenta[a]naphthalene-3-carboxylic acid C19H28O5 详情 详情
(IX) 13010 (4aR,4bS,6aS,7S,9aS,9bS)-4a,6a-Dimethyl-2-oxo-2,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid C19H27NO3 详情 详情
(X) 22453 (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid C19H29NO3 详情 详情
(XI) 13527 methyl (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate C20H31NO3 详情 详情
(XII) 13009 methyl (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate C20H29NO3 详情 详情
(XIII) 13533 (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid C19H27NO3 详情 详情
(XIV) 22457 2,2'-Dithiodipyridine; 2-(2-pyridinyldisulfanyl)pyridine; 2,2'-Dipyridinyl disulfide 2127-03-9 C10H8N2S2 详情 详情
(XV) 22458 S-(2-pyridinyl) (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carbothioate C24H30N2O2S 详情 详情
(XVI) 18975 (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carbonyl chloride C19H26ClNO2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(V)

Title compound was prepared by two synthetic ways: 1) Treatment of hexafluorophenylpropanol (I) with KH and then with trifluoromethane- sulfonic anhydride gave triflate (II), which was converted into azide (III) by reaction with NaN3 in trifluoroacetic acid. Reduction of azide (III) with Raney-nickel in isopropanol afforded the corresponding amine, which was isolated as the hydrochloride salt (IV). Acid chloride (VI) was prepared from acid (V) by treatment with SOCl2. Then, condensation of (VI) with amine (IV) in the presence of pyridine provided the target amide.

1 Panzeri, A.; Nesi, M.; Di Salle, E. (Pharmacia & Upjohn AB); Phenylsubstd. 4-azasteroid fluoroderivs.. EP 0793671; JP 1998509188; US 5922728; WO 9710257 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18970 1,1,1,3,3,3-hexafluoro-2-phenyl-2-propanol 718-64-9 C9H6F6O 详情 详情
(II) 18971 2,2,2-trifluoro-1-phenyl-1-(trifluoromethyl)ethyl trifluoromethanesulfonate C10H5F9O3S 详情 详情
(III) 18972 1-[1-azido-2,2,2-trifluoro-1-(trifluoromethyl)ethyl]benzene; 2,2,2-trifluoro-1-phenyl-1-(trifluoromethyl)ethyl azide C9H5F6N3 详情 详情
(IV) 18973 1,1,1,3,3,3-hexafluoro-2-phenyl-2-propanamine hydrochloride C9H8ClF6N 详情 详情
(V) 13533 (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid C19H27NO3 详情 详情
(VI) 18975 (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carbonyl chloride C19H26ClNO2 详情 详情
(VII) 14982 (2R,3R,7S,10R)-7-[(2S,3E,5E,7E,9S,11R)-11-(1,3-dithian-2-yl)-2-methoxy-3,9-dimethyl-3,5,7-dodecatrienyl]-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]decane; (1S,2E,4E,6E,8S,10R)-10-(1,3-dithian-2-yl)-2,8-dimethyl-1-[[(2R,3R,7S,10R)-2,3,10-trimethyl-1,4,6-trioxaspiro[4.5]dec-7-yl]methyl]-2,4,6-undecatrienyl methyl ether C29H48O4S2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(V)

 

1 Davis R,Millar A, et 2002. Preparation of 3-oxo-4-azasteroids via stereoselective hydrogenation.W0 2002046207
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14892 (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylic acid; 4-Androstene-3-oxo-17-beta-carboxylic acid 7385-78-6 C20H28O3 详情 详情
(II) 22451 (3S,3aS,5aS,6R,9aS,9bS)-6-(2-carboxyethyl)-3a,6-dimethyl-7-oxododecahydro-1H-cyclopenta[a]naphthalene-3-carboxylic acid C19H28O5 详情 详情
(III) 13010 (4aR,4bS,6aS,7S,9aS,9bS)-4a,6a-Dimethyl-2-oxo-2,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid C19H27NO3 详情 详情
(IV) 22453 (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid C19H29NO3 详情 详情
(V) 13533 (4aS,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid C19H27NO3 详情 详情
Extended Information